Location History:
- Castanet Tolosan, FR (1992)
- Castenet, FR (2009 - 2010)
- Castanet, FR (1992 - 2012)
- Toulouse, FR (2020)
Company Filing History:
8 out of 5,072 
2 out of 336 
2 out of 14 
Years Active: 1992-2020
Title: Innovator in Neurodegenerative Disease Research: The Patents of Bernard Meunier
Introduction: Bernard Meunier, an esteemed inventor based in Castanet, France, has made significant contributions to the field of medical research, particularly focusing on neurodegenerative diseases. With a remarkable portfolio of 15 patents, Meunier is recognized for his innovative strategies in chelating metal ions and developing therapeutic applications for various disorders.
Latest Patents: Among his latest inventions are two notable patents. The first is a "Tetradentate chelating monoquinoline derivative, manufacturing method thereof, and application of same as metal ion regulator for neurodegenerative disease." This invention centers around a tetradentate chelating monoquinoline derivative designed to specifically chelate redox-active metal ions like copper, which are typically dysregulated in diseases such as Alzheimer's, Huntington's, Parkinson's, and Wilson's disease. These compounds exhibit an impressive ability to reduce oxidative stress while demonstrating significantly lower binding constants for zinc compared to copper, indicating their potential in drug manufacturing for neurodegenerative diseases and conditions related to copper metabolism.
The second patent, titled "Polyquinoline derivatives and the therapeutic use thereof," outlines a method for effectively chelating metal ions and dissolving amyloid aggregates. This method employs a compound of a specific formula, contributing further to the therapeutic strategies for managing metal ion-related disorders.
Career Highlights: Throughout his career, Bernard Meunier has collaborated with prestigious research institutions, including the French National Centre for Scientific Research (CNRS) and Atochem, where he harnessed his expertise in innovative chemical solutions. His work has been pivotal in advancing therapies for debilitating neurodegenerative conditions, emphasizing the importance of metal ion regulation.
Collaborations: Meunier's contributions have been enriched by collaboration with distinguished researchers such as Jean-Pierre Majoral and Anne-Marie Caminade. These partnerships have facilitated a multidisciplinary approach, enhancing the scope and impact of his research initiatives.
Conclusion: Bernard Meunier's inventive spirit and dedication to tackling complex medical challenges have established him as a prominent figure in the realm of neurodegenerative research. His extensive patent portfolio not only reflects his innovative prowess but also highlights the potential for future breakthroughs in the treatment of diseases caused by metal ion dysregulation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.